UNSPSC 51401559: Camazepam

This classification denotes a benzodiazepine tranquilizer and temazepam analog with the molecular formula C19H18ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HZ3XRH03C3, chemically known as 7-chloro-1,3-dihydro-3-(n,n-dimethylcarbamoyl)-1-methyl-5-phenyl-2h-1,4-benzodiazepin-2-one but generally known as camazepam, which bears US NIH Compound Identifier 37367. European Medicines Agency schedules Camazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06061MIG.

UNSPSC 51401559 Camazepam is a Commodity code that does not reflect the scope of work actually being solicited under it in state and local procurement. The recent opportunities tagged to this code involve naloxone procurement, therapeutic pharmacy initiatives, and generic multi-source pharmaceutical distribution—none of which concern camazepam, a benzodiazepine anxiolytic rarely if ever appearing in state and local government purchasing. The code shows minimal relevant recent activity; the three most recent state and local solicitations are plainly unrelated to the commodity's nominal scope.

The issuing bodies represent different tiers of government—Seminole County, Florida (county health authority), the Texas Health and Human Services Commission (state agency), and the Minnesota Multistate Cooperative Purchasing Alliance (multi-state cooperative)—but their procurement focuses on emergency response pharmaceuticals, pharmacy benefit program redesign, and generic drug distribution channels rather than the benzodiazepine class. Geographic activity spans Florida, Texas, and Minnesota, but these jurisdictions are purchasing across broader pharmaceutical categories, not camazepam specifically. The mismatch between the UNSPSC code and the actual procurement scope suggests either a tagging error in the state and local systems or that this commodity code is not actively used for what state and local governments currently buy.